EpiWafer Technology Starts “Series A” on its Way to Commercialization – NexWafe GmbH and Lynwood (Schweiz) AG sign investment contract

NexWafe, a Fraunhofer ISE spin-off founded in June 2015, is now starting “Series A”, commercializing its EpiWafer technology after signing a funding contract with Lynwood (Schweiz) AG.

© Fraunhofer ISE
Epitaxial Wafer (right) detached from re-usable seed wafer (left).

NexWafe's highly innovative EpiWafer technology developed at Fraunhofer ISE is based on epitaxy and is a drop-in replacement for conventional wafers produced by a single-crystal ingot and wire sawing process.

More information: http://www.nexwafe.com/NEWS/

Last modified: